Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Back
  4. Sexual Health
  5. Lymphogranuloma Venereum and Proctitis (956)

Lymphogranuloma Venereum and Proctitis (956)

Mpox virus must be considered in anyone presenting with suspected sexually-acquired
proctitis

Management of acute undifferentiated proctitis in Sandyford may be subject to
change due to infection control concerns

There have been no updates to national LGV guidance since 2013

Resources

Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 11/12/2024

Next review date: 30/09/2026

Author(s): Kay McAllister.

Version: 3

Author email(s): kay.mcallister2@nhs.scot.

Approved By: Sandyford Governance Group

Document Id: 956

References

2019 European guideline on the management of lymphogranuloma venereum.
IUSTI guideline. Available at: https://iusti.org/treatment-guidelines/  [Accessed 17/09/2024]


2013 UK National Guideline for the management of lymphogranuloma venereum:
Clinical Effectiveness Group of the British Association for Sexual Health and HIV
(CEG/BASHH) Guideline development group. BASHH guideline. Available at:https://www.bashh.org/resources/guidelines [Accessed 17/09/2024]


Public Health England. Trends of Lymphogranuloma venereum (LGV) in England,
2019. Health Protection Report 14 (23) Dec 2020]. Available at:https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1011030/hpr2320_LGV-11.pdf [accessed 17/09/2024]

UKHSA Mpox (monkeypox) guidance
https://www.gov.uk/government/collections/monkeypox-guidance [accessed
17/09/2024]